Poietis
Poietis is a biotechnology company specialized in the development and manufacturing of human tissues by 4D bioprinting. Since its inception in 2014 the company has been developing physiological models, particularly in partnership with the world’s leading pharmaceutical and cosmetic groups. Poietis markets Poieskin, the first commercial bio-printed human tissue. On the basis of its expertise in bioprinting technologies and in particular high resolution laser bioprinting, Poietis has also developed the multimodal bioprinting platform NGB (Next Generation Bioprinting). NGB platform aims to give tissue engineers and researchers greater freedom in the choice of biomaterials and hydrogels and greater versatility in their research and development.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Internationally (various countries)
About Us
Besides the NGB-R commercial bioprinter dedicated to R&D, the compagny is developing the NGB-C system for clinical applications. Based on the same core technology as NGB-R, NGB-C will meet the requirements of translational research and challenges of industrial manufacturing of implantable tissues.
The bioprinting technology of Poietis, whose company is licensed exclusively and worldwide, is the result of an innovative research conducted for ten years by Inserm and the University of Bordeaux. Poietis won the iLab competition in 2014, is the winner of the World Innovation Challenge, Phase I in 2016, and Phase II in 2017, and won the Ernst & Young Disruptive Strategy Award in 2018.